Pesquisas alternativas:
can company » bain company (Expandir a Pesquisa), japan company (Expandir a Pesquisa), ramon company (Expandir a Pesquisa)
a company » _ company (Expandir a Pesquisa)
co2 can » co2 dan (Expandir a Pesquisa), co2 case (Expandir a Pesquisa), co2 dans (Expandir a Pesquisa)
j naila » j nail (Expandir a Pesquisa), j nakkila (Expandir a Pesquisa), jan naila (Expandir a Pesquisa)
naila a » laila a (Expandir a Pesquisa), nail a (Expandir a Pesquisa), naila c (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
l co2 » al co2 (Expandir a Pesquisa), el co2 (Expandir a Pesquisa), _ co2 (Expandir a Pesquisa)
a dan » a day (Expandir a Pesquisa), _ dan (Expandir a Pesquisa), a don (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
can company » bain company (Expandir a Pesquisa), japan company (Expandir a Pesquisa), ramon company (Expandir a Pesquisa)
a company » _ company (Expandir a Pesquisa)
co2 can » co2 dan (Expandir a Pesquisa), co2 case (Expandir a Pesquisa), co2 dans (Expandir a Pesquisa)
j naila » j nail (Expandir a Pesquisa), j nakkila (Expandir a Pesquisa), jan naila (Expandir a Pesquisa)
naila a » laila a (Expandir a Pesquisa), nail a (Expandir a Pesquisa), naila c (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
l co2 » al co2 (Expandir a Pesquisa), el co2 (Expandir a Pesquisa), _ co2 (Expandir a Pesquisa)
a dan » a day (Expandir a Pesquisa), _ dan (Expandir a Pesquisa), a don (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
1
Por Planas, O., Roldán-Gómez, S., Martin-Diaconescu, V., Luis, J. M., Company, A., Ribas, X.
Publicado no Chem Sci (2018)
“...Herein we describe the synthesis and characterization of a family of C-metalated aryl-Co(iii...”Publicado no Chem Sci (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Fernández, L Lorente, Crespo, M Belló, Roman, A Santiuste, Hernández, M Montero, Rausell, M Monzó, Company, E Soler
Publicado no Eur J Hosp Pharm (2018)
“... with autologous serum eye drops respond with good tolerance and few or no side-effects, although it can produce a...”Publicado no Eur J Hosp Pharm (2018)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Clavel-Henry, Morane, Solé, Jordi, Kristiansen, Trond, Bahamon, Nixon, Rotllant, Guiomar, Company, Joan B.
Publicado no PLoS One (2020)
“..., it has hardly been explored if this buoyancy variability can be a strategy for deep-sea larvae...”Publicado no PLoS One (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
5
Por Company Pfizer
Publicado em 2019-09-01
“...Pfizer Company Press Release....”Publicado em 2019-09-01
Obter o texto integral
Artigo
6
Por Company Company, Concepción, Godinas, Laurette, Higashi, Alejandro, Clark de Lara, Belem
Publicado em 2009
Assuntos:
“...thema EDItEUR::D Biography, Literature and Literary studies::DN Biography and non-fiction prose...”Publicado em 2009
Obter o texto integral
Livro
7
“... for management, analyzing groups of agents associated with a significant effect on the risk of infection. Due...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Muñoz, S García, Martínez, T García, Rausell, M Monzo, Albertos, M Bellver, Román, A Santiuste, Company, E Soler
Publicado no Eur J Hosp Pharm (2018)
“... for resistance and three cases of non-descalation. In fact, opportunities for improvement have been identified...”Publicado no Eur J Hosp Pharm (2018)
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ibáñez-Alfonso, Joaquín A., Company-Córdoba, Rosalba, García de la Cadena, Claudia, Sianes, Antonio, Simpson, Ian Craig
Publicado no Children (Basel) (2021)
“... children and adolescents aged from 6 to 17 years (M = 10.8, SD = 3) in a series of 10 neuropsychological...”Publicado no Children (Basel) (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por McNew, Kelsey L., Whipple, William J., Mehta, Anita K., Grant, Trevor J., Ray, Leah, Kenny, Connor, Singh, Anurag
Publicado no Mol Cancer Res (2016)
“... agents may enhance efficacy. Here, co-dependencies of MEK, TAK1 and KRAS in colon cancer were...”Publicado no Mol Cancer Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Beyhun, Nazim Ercument, Kolayli, Cevriye Ceyda, Can, Gamze, Topbas, Murat
Publicado no PLoS One (2016)
“... not accept any gift from a drug company.” (0.3[0.1–0.9], p = 0.030). In summary, exposure to drug companies...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Company-Quiroga, Jaime, Alique-García, Sergio, Romero-Maté, Alberto
Publicado no Clin Cosmet Investig Dermatol (2019)
“... lupus erythematosus. Although most patients will respond to lifestyle measures and topical treatment, a...”Publicado no Clin Cosmet Investig Dermatol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Bellot-Arcís, Carlos, Montiel-Company, José María, Almerich-Silla, José Manuel
Publicado em 2013
“... in adolescents. METHODS: A random sample of 627 Spanish adolescents aged 12 - 15 years underwent intraoral...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por González–Gil-de-Bernabé, Paloma, Bellot-Arcís, Carlos, Montiel-Company, José M., Gandía-Franco, José L.
Publicado no J Clin Exp Dent (2014)
“... the orthodontic treatment outcome in a post-graduate orthodontics program in the University of Valencia (Spain...”Publicado no J Clin Exp Dent (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... in public and in non-public companies. Besides, there are some external factors which prevent Russian...”
Obter o texto integral
Obter o texto integral
Artigo
16
“... of Herpystis, which is a non-pollinating seed parasite. CONCLUSIONS: Our study reveals new complexity...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Anguiano-Álvarez, Víctor Manuel, Hernández-Company, Alonso, Hamdan-Pérez, Nashla, Montante-M, Daniel, Zúñiga-Tamayo, Diego A., Rodríguez-Rodríguez, Sergio, Pomerantz, Alan, Tuna-Aguilar, Elena J.
Publicado no Blood Res (2018)
“...: 0.98–0.99, P=0.03) were protective factors for SMM; and anti-dsDNA titer higher than 9.6 IU/dL was a...”Publicado no Blood Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
19
Por Boronat-Catalá, Montserrat, Montiel-Company, José María, Bellot-Arcís, Carlos, Almerich-Silla, José Manuel, Catalá-Pizarro, Montserrat
Publicado no Sci Rep (2017)
“... of posterior crossbite was 3.76 (95% CI 2.01–7.03) on comparing children who had not been breastfed, with those...”Publicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Assuntos:
“...non-financial indicators, fraudulent bankruptcy, forensic accounting expertise, pre-bankruptcy...”
Obter o texto integral
Obter o texto integral
Artigo